OXB vs. ONT, GNS, ERGO, SLN, PRTC, HZD, VRP, FARN, AVCT, and ARIX
Should you be buying Oxford Biomedica stock or one of its competitors? The main competitors of Oxford Biomedica include Oxford Nanopore Technologies (ONT), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Avacta Group (AVCT), and Arix Bioscience (ARIX). These companies are all part of the "biotechnology" industry.
Oxford Biomedica vs.
Oxford Nanopore Technologies (LON:ONT) and Oxford Biomedica (LON:OXB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings.
In the previous week, Oxford Nanopore Technologies had 1 more articles in the media than Oxford Biomedica. MarketBeat recorded 1 mentions for Oxford Nanopore Technologies and 0 mentions for Oxford Biomedica. Oxford Nanopore Technologies' average media sentiment score of 0.34 beat Oxford Biomedica's score of 0.00 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.
Oxford Nanopore Technologies presently has a consensus price target of GBX 235.50, indicating a potential upside of 51.94%. Oxford Biomedica has a consensus price target of GBX 433.33, indicating a potential upside of 4.42%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Oxford Nanopore Technologies is more favorable than Oxford Biomedica.
Oxford Biomedica has lower revenue, but higher earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Oxford Biomedica, indicating that it is currently the more affordable of the two stocks.
38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. Comparatively, 64.1% of Oxford Biomedica shares are owned by institutional investors. 32.6% of Oxford Nanopore Technologies shares are owned by insiders. Comparatively, 21.2% of Oxford Biomedica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Oxford Nanopore Technologies has a net margin of -94.82% compared to Oxford Biomedica's net margin of -145.98%. Oxford Nanopore Technologies' return on equity of -26.08% beat Oxford Biomedica's return on equity.
Oxford Nanopore Technologies has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Oxford Biomedica has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.
Oxford Biomedica received 326 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 66.73% of users gave Oxford Biomedica an outperform vote.
Summary
Oxford Nanopore Technologies beats Oxford Biomedica on 12 of the 18 factors compared between the two stocks.
Get Oxford Biomedica News Delivered to You Automatically
Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Biomedica Competitors List
Related Companies and Tools
This page (LON:OXB) was last updated on 1/21/2025 by MarketBeat.com Staff
